HIV/AIDS Clinical Trial
Recent findings from University of Hawaii highlight research in HIV/AIDS clinical trial
Published in AIDS Weekly, May 7th, 2007
New investigation results, "Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)," are detailed in a study published in Journal of Acquired Immune Deficiency Syndromes. In this recently published article, scientists in the United States conducted a study "To assess metabolic changes after initiation of protease inhibitor (PI)-sparing regimens in antiretroviral-naive patients. Metabolic changes were analyzed within the triple-nucleoside (zidovudine [ZDV]/lamivudine [3TC]/abacavir [ABC])-containing, 3-drug efavirenz (EFV) [ZDV/3TC + EFV]-containing, and 4-drug EFV [ZDV/3TC/ABC +...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-05-07)
More Articles from AIDS Weekly
- HIV/AIDS
HIV infection appears to increases the risk of heart attack - HIV/AIDS
Resistance to anti-HIV drugs in Uganda developed due to drug supply problems - HIV/AIDS
Surge in senior HIV survivors prompts new treatment studies - DNA Vaccines
VGX Pharmaceuticals Announces DNA Vaccines License Agreement with University of Pennsylvania - HIV/AIDS
Abbott Continues Drug Blacklist in Thailand, Says AIDS Healthcare Foundation - HIV/AIDS
ADVENTRX ANX-201 Abstract Accepted for Presentation at International AIDS Conference - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
